Search research articles
Contact Us
Filters
Showing results (241-250 of 316) with videos related to
Page
of 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2011
Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age
Denah R Taggart, Wendy B London, Mary Lou Schmidt, et al.
Pediatric Blood & Cancer
|
October 22, 2008
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group
Julie R Park, Judith G Villablanca, Wendy B London, et al.
Pediatric Blood & Cancer
|
July 28, 2011
Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study
Steven G DuBois, Robert Goldsby, Mark Segal, et al.
Molecular Imaging and Biology
|
March 3, 2012
Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model
Youngho Seo, W Clay Gustafson, Shorouk F Dannoon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2013
Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group
Gregory A Yanik, Marguerite T Parisi, Barry L Shulkin, et al.
Cancer Chemotherapy and Pharmacology
|
February 23, 2011
Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study
Jane E Minturn, Audrey E Evans, Judith G Villablanca, et al.
The New England Journal of Medicine
|
October 16, 1999
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group
K K Matthay, J G Villablanca, R C Seeger, et al.
Cancer Cell
|
September 2, 2014
Drugging MYCN through an allosteric transition in Aurora kinase A
William Clay Gustafson, Justin Gabriel Meyerowitz, Erin A Nekritz, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 5, 2015
Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group
William Temple, Lori Mendelsohn, Grace E Kim, et al.
Journal of Pediatric Hematology/Oncology
|
June 11, 1999
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival
S G DuBois, Y Kalika, J N Lukens, et al.
Page
of 32
Search research articles
Search
Showing results (241-250 of 316) with videos related to
Sort By:
Page
of 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2011
Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age
Denah R Taggart, Wendy B London, Mary Lou Schmidt, et al.
Pediatric Blood & Cancer
|
October 22, 2008
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group
Julie R Park, Judith G Villablanca, Wendy B London, et al.
Pediatric Blood & Cancer
|
July 28, 2011
Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study
Steven G DuBois, Robert Goldsby, Mark Segal, et al.
Molecular Imaging and Biology
|
March 3, 2012
Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model
Youngho Seo, W Clay Gustafson, Shorouk F Dannoon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2013
Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group
Gregory A Yanik, Marguerite T Parisi, Barry L Shulkin, et al.
Cancer Chemotherapy and Pharmacology
|
February 23, 2011
Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study
Jane E Minturn, Audrey E Evans, Judith G Villablanca, et al.
The New England Journal of Medicine
|
October 16, 1999
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group
K K Matthay, J G Villablanca, R C Seeger, et al.
Cancer Cell
|
September 2, 2014
Drugging MYCN through an allosteric transition in Aurora kinase A
William Clay Gustafson, Justin Gabriel Meyerowitz, Erin A Nekritz, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 5, 2015
Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group
William Temple, Lori Mendelsohn, Grace E Kim, et al.
Journal of Pediatric Hematology/Oncology
|
June 11, 1999
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival
S G DuBois, Y Kalika, J N Lukens, et al.
Page
of 32